Company Overview

Company name: Sativa Nativa
Description: Producer and distributor of cannabis based medical products. The company’s medical cannabis distribution business include importing, exporting and supplying of narcotic drugs, licensed medical marijuana and other related products for medical purposes in Canada, enabling physicians to help ease stress and anxiety while boosting relaxation to their patients.
Year founded:
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
City: Santa Marta
Country: Colombia
Region: Americas

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (no backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company reached a definitive agreement to be acquired by Pure Global Cannabis (TSX.V: PURE) for CAD 18.9 million on August 15, 2018. The acquisition will leverage the acquirer to produce low-cost inputs for value-added products destined for emerging export markets.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation: 24.15
Last known valuation date: 15-Aug-2018